These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18941022)

  • 1. Anaphylaxis following single component measles and rubella immunisation.
    Erlewyn-Lajeunesse M; Manek R; Lingam R; Finn A; Emond A
    Arch Dis Child; 2008 Nov; 93(11):974-5. PubMed ID: 18941022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008.
    Khetsuriani N; Imnadze P; Baidoshvili L; Jabidze L; Tatishili N; Kurtsikashvili G; Lezhava T; Laurent E; Martin R
    Vaccine; 2010 Sep; 28(39):6455-62. PubMed ID: 20674880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis as an adverse event following immunisation in the UK and Ireland.
    Erlewyn-Lajeunesse M; Hunt LP; Heath PT; Finn A
    Arch Dis Child; 2012 Jun; 97(6):487-90. PubMed ID: 22275307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles and rubella vaccination of two million Iranians: complications in vaccinees aged 5-25 years.
    Vahdani P; Aminzadeh Z; Alimardani M; Sharafi A
    Scand J Infect Dis; 2005; 37(11-12):913-5. PubMed ID: 16308230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral hearing loss after measles and rubella vaccination in an adult.
    Hulbert TV; Larsen RA; Davis CL; Holtom PD
    N Engl J Med; 1991 Jul; 325(2):134. PubMed ID: 2052052
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of serious neurologic disease after immunization of young children in Britain and Ireland.
    Ward KN; Bryant NJ; Andrews NJ; Bowley JS; Ohrling A; Verity CM; Ross EM; Miller E
    Pediatrics; 2007 Aug; 120(2):314-21. PubMed ID: 17671057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibody development and frequency of events temporarily associated with measles and rubella vaccines among university health personnel in Jalisco].
    Villaseñor-Sierra A; Santos-Preciado JI; Alvarez-y-Muñoz MT; Rivas-García ME; Martínez-Sandoval F; Falcón-Franco MA
    Gac Med Mex; 2005; 141(6):455-9. PubMed ID: 16381498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded programme on immunization (EPI). Adverse events following administration of measles-rubella vaccine.
    Wkly Epidemiol Rec; 1996 Oct; 71(43):321-3. PubMed ID: 9238416
    [No Abstract]   [Full Text] [Related]  

  • 11. The first rapid onset optic neuritis after measles-rubella vaccination: case report.
    Arshi S; Sadeghi-Bazargani H; Ojaghi H; Savadi-Oskouei D; Hekmat S; Jastan M; Majidpour A; Shahizareh F
    Vaccine; 2004 Sep; 22(25-26):3240-2. PubMed ID: 15308345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between occurrence of Guillain-Barre syndrome and mass campaign of measles and rubella immunization in Iranian 5-14 years old children.
    Esteghamati A; Gouya MM; Keshtkar AA; Mahoney F
    Vaccine; 2008 Sep; 26(39):5058-61. PubMed ID: 18662736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ; Montgomery SM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles, mumps, and rubella: prevention.
    Booy R; Sengupta N; Bedford H; Elliman D
    Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles vaccine adverse events reported in the mass vaccination campaign of Sichuan province, China from 2007 to 2008.
    Shu M; Liu Q; Wang J; Ao R; Yang C; Fang G; Wan C; Guo W
    Vaccine; 2011 Apr; 29(18):3507-10. PubMed ID: 19909830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Bilateral Photoreceptor Degeneration in an Infant After Vaccination Against Measles and Rubella.
    Kuniyoshi K; Hatsukawa Y; Kimura S; Fujino T; Ohguro H; Nakai R; Sunami K; Mishima SI; Sato T; Kusaka S; Suzuki Y; Shimomura Y
    JAMA Ophthalmol; 2017 May; 135(5):478-482. PubMed ID: 28358967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura following measles-rubella-conjugated vaccine.
    Kitazawa J; Ohtani K; Shiotani M; Satoh A; Sugimoto K; Nomura Y; Aoyama R
    Pediatr Int; 2007 Oct; 49(5):688-9. PubMed ID: 17875104
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccination and autoimmunity.
    Nossal GJ
    J Autoimmun; 2000 Feb; 14(1):13-5. PubMed ID: 10648112
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence of Kawasaki disease after simultaneous immunization.
    Matsubara D; Minami T; Seki M; Tamura D; Yamagata T
    Pediatr Int; 2019 Nov; 61(11):1171-1173. PubMed ID: 31709668
    [No Abstract]   [Full Text] [Related]  

  • 20. Naive and memory CD4+ T-cells in the cerebrospinal fluid of children with aseptic meningitis following measles-mumps-rubella vaccination and enteroviral meningitis.
    Lepej SZ; Tesovic G; Sternak SL; Jeren T
    Immunol Invest; 2007; 36(3):321-35. PubMed ID: 17558714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.